Immuto Scientific

Immuto Scientific

Private
Madison, WisconsinHealthcare & Life Scienceshttps://immutoscientific.com

Last Round

Seed

Sep 18, 2025

Total Funding Raised

$13.84M

Momentum Score

50 /100

Company Overview

Immuto Scientific is a biotechnology company that provides analytical research services for drug discovery using its proprietary platform for protein structural analysis.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROdrug target discoveryAI drug discoverystructural surfaceomicstarget identificationtarget IDprotein structure analysisproteomics servicesAI structural biologymass spectrometry servicesepitope mappinghigher order structure analysisHOS analysisprotein conformation analysisoncology drug discoveryprotein-protein interactionbiopharma services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immuto Scientific Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Immuto Scientific Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 18, 2025
GrantAug 15, 2022
SeedOct 12, 2021
GrantMar 10, 2020

Key People

Founding team and executive leadership

Daniel Benjamin

Co-Founder, Chief Technology Officer

Founding Team

Faraz A. Choudhury

Co-founder And CEO

Founding Team

Immuto Scientific Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Partnered with Daiichi Sankyo Co. Ltd. on drug discovery.

  • Sep 18, 2025

    $8M raised in Seed round.

Immuto Scientific Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Immuto Scientific Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Immuto Scientific's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range19
Year Founded2018
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.